login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ONKURE THERAPEUTICS INC-A (OKUR) Stock News
USA
- NASDAQ:OKUR -
US68277Q1058
-
Common Stock
3.33
USD
-0.24 (-6.72%)
Last: 10/28/2025, 8:14:29 PM
3.25
USD
-0.08 (-2.4%)
Pre-Market:
10/29/2025, 8:44:20 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OKUR Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: OnKure Therapeutics, Inc.
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
6 months ago - By: OnKure Therapeutics, Inc.
OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
8 months ago - By: Benzinga
- Mentions:
GILD
ORCL
S
VG
...
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
8 months ago - By: OnKure Therapeutics, Inc.
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
10 months ago - By: Benzinga
- Mentions:
CSBR
OGEN
ATXI
VERO
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
a year ago - By: OnKure Therapeutics, Inc.
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
a year ago - By: OnKure Therapeutics, Inc.
OnKure Announces New Date for Upcoming Investor Call
a year ago - By: OnKure Therapeutics, Inc.
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
a year ago - By: Reneo Pharmaceuticals, Inc.; OnKure Therapeutics, Inc.
- Mentions:
RPHM
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
Please enable JavaScript to continue using this application.